Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

FGF19-FGFR4 pathway has dual roles in liver health and cancer

17

Nov 2026

FGF19-FGFR4 pathway has dual roles in liver health and cancer

A review published in Genes & Diseases examines a pathway that can both protect the liver and contribute to its destruction. Researchers at Tongji Hospital, Huazhong University of Science and Technology, describe how FGF19-FGFR4 signalling regulates metabolism and tissue repair, while abnormal activation can promote liver cancer and complicate treatment.

E-scooters linked to increased head and neck injury risk

17

Nov 2026

E-scooters linked to increased head and neck injury risk

Adults injured while riding e-scooters had a higher risk of serious head or neck injury than those injured on bicycles, even though their injuries were less severe overall, according to a national trauma-center analysis published in the Journal of the American College of Surgeons (JACS).

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.